Advocacy intelligence hub — real-time data for patient organizations
Totect(r): FDA approved
Treatment of extravasation resulting from IV anthracycline chemotherapy
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Totect
(dexrazoxane)Orphan drugClinigen, Inc.
12.1 Mechanism of Action The mechanism by which dexrazoxane for injection exerts its cytoprotective activity is not fully understood. Dexrazoxane is a...
View all OBSOLETE: Anthracycline extravasation specialists →